A requirement that manufacturers demonstrate that the infant formulas they produce support normal physical growth.
Current good manufacturing practices specifically designed for infant formula - including required testing for the harmful pathogens (disease-causing bacteria) Salmonella and Cronobacter.In light of comments received after the interim rule published last February, the final rule provides some modifications and clarifications, and sets a date of September 8, 2014, for manufacturer compliance. The Food and Drug Administration (FDA) is putting the finishing touches on a rule that sets standards for manufacturers of infant formula.
0 kommentar(er)
